Why is Concord Biotech falling/rising?

As of 09-Jul, Concord Biotech Ltd's stock price is currently at Rs 1,819.45, reflecting an increase of Rs 27.3 or 1.52%. The stock has shown a positive trend recently, gaining 4.59% over the last three days and outperforming its sector by 1.32% today. Additionally, the stock has touched an intraday high of Rs 1,875, indicating strong buying interest. Despite a year-to-date decline of 17.67%, the company has demonstrated strong fundamentals, with a significant growth in net sales and profit after tax in its latest quarterly results. The increase in institutional investor participation, with a 0.52% rise in their stake, further supports the stock's upward movement.
In the broader market context, Concord Biotech's short-term performance over the past week shows a return of +3.53%, significantly outperforming the Sensex, which only increased by 0.15% during the same period. This indicates that while the stock has faced challenges in the longer term, its recent performance is encouraging, suggesting a potential recovery phase. The company's solid long-term fundamentals, including a healthy return on equity and low debt-to-equity ratio, combined with rising investor interest, contribute positively to its current stock price movement.